NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2025
Voltar para busca
Dado oficial do USPTO
VAPOURSOFT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
12/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
29/01/2014
Data de registro
22/09/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/04/2022
Última transação
12/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BUONGIORNO,CHRISTOPHER L
Unidade examinadora
L20
Localização atual
TMEG LAW OFFICE 103
Titulares e representantes
Titulares
Consort Medical Limited
Consort Medical Plc
Representantes
Norm J. Rich Foley & Lardner LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery deviceshydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectors for administrating pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugs; hydrofluoroalkanes (HFA) powered devicesapparatus and instruments for use with drug and pharmaceutical delivery devices that convey drug and pharmaceutical delivery dosagemeasuring and monitoring information through audiovisual and/or tactile patient feedback mechanisms; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectors and apparatus and devices in the nature of drug delivery systems incorporating audiovisual and/or tactile patient feedback mechanisms to convey dosagemeasuringmonitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugsmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugshypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges for medical syringes; nozzles for medical syringes; drug delivery apparatusdrug delivery systemselectromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensersnasal aspiratorsaerosol dispensers for medical use; aerosol dispensers for medical purposes; parts and fittings for all the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
Further Decision Processed by IB
26/04/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
25/02/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
25/02/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
25/02/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
29/02/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/12/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
31/10/2022
RFNT
REFUSAL PROCESSED BY IB
10/04/2022
C71T
CANCELLED SECTION 71
08/04/2022
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
21/12/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/12/2021
XXXX
POST REGISTRATION ACTION CORRECTION
10/12/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/11/2021
RFNT
REFUSAL PROCESSED BY IB
18/07/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/10/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/09/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/05/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/03/2016
FIMP
FINAL DISPOSITION PROCESSED
19/03/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/12/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
22/09/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2015
PUBO
PUBLISHED FOR OPPOSITION
07/07/2015
GPNX
NOTIFICATION PROCESSED BY IB
03/07/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/06/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/06/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/06/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/06/2015
ALIE
ASSIGNED TO LIE
03/06/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
11/05/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/05/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
11/05/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/05/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/12/2014
GNFR
FINAL REFUSAL E-MAILED
09/12/2014
CNFR
FINAL REFUSAL WRITTEN
09/12/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/08/2014
RFNT
REFUSAL PROCESSED BY IB
20/06/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/05/2014
RFRR
REFUSAL PROCESSED BY MPU
27/05/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/05/2014
CNRT
NON-FINAL ACTION WRITTEN
24/05/2014
MAFR
APPLICATION FILING RECEIPT MAILED
23/05/2014
DOCK
ASSIGNED TO EXAMINER
19/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/05/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/05/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VAPOURSOFT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.